109 related articles for article (PubMed ID: 3463363)
1. Chronic myelogenous leukaemia: haematological remissions with alpha interferon.
Talpaz M; McCredie K; Kantarjian H; Trujillo J; Keating M; Gutterman J
Br J Haematol; 1986 Sep; 64(1):87-95. PubMed ID: 3463363
[TBL] [Abstract][Full Text] [Related]
2. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
Talpaz M; Kantarjian HM; McCredie K; Trujillo JM; Keating MJ; Gutterman JU
N Engl J Med; 1986 Apr; 314(17):1065-9. PubMed ID: 3457264
[TBL] [Abstract][Full Text] [Related]
3. Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferon.
Talpaz M; Trujillo JM; Hittelman WN; Keating MJ; Gutterman JU
Br J Haematol; 1985 Aug; 60(4):619-24. PubMed ID: 3861194
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigation of human alpha interferon in chronic myelogenous leukemia.
Talpaz M; Kantarjian HM; McCredie KB; Keating MJ; Trujillo J; Gutterman J
Blood; 1987 May; 69(5):1280-8. PubMed ID: 3471281
[TBL] [Abstract][Full Text] [Related]
5. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
[TBL] [Abstract][Full Text] [Related]
6. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.
Kloke O; Becher R; Niederle N
Blut; 1987 Nov; 55(5):453-8. PubMed ID: 3118992
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemia.
Yoffe G; Blick M; Kantarjian H; Spitzer G; Gutterman J; Talpaz M
Blood; 1987 Mar; 69(3):961-3. PubMed ID: 2880616
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration.
Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inverardi D; Bernasconi P; Mancini M; Donti E; Grignani F
Blood; 1988 Aug; 72(2):642-7. PubMed ID: 3165298
[TBL] [Abstract][Full Text] [Related]
9. [alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia].
Niederle N; Kloke O; Doberauer C; Becher R; Beelen DW; Schmidt CG
Dtsch Med Wochenschr; 1986 May; 111(20):767-72. PubMed ID: 3516621
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human interferon-alpha induced cytoreduction in chronic myelogenous leukemia. Results of a multicenter study.
Werter M; de Witte R; Janssen J; de Pauw B; Haanen C
Blut; 1988 May; 56(5):209-12. PubMed ID: 3285912
[TBL] [Abstract][Full Text] [Related]
11. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; LeMaistre CF; Spinolo J; Spitzer G; Yau J; Dicke K; Jagannath S; Deisseroth AB
Cancer; 1991 Jun; 67(12):2959-65. PubMed ID: 1675151
[TBL] [Abstract][Full Text] [Related]
12. Ph1 negative haematological chimaerism after marrow transplantation in Ph1 positive chronic granulocytic leukaemia.
Vincent PC; Young GA; Singh S; Atkinson K; Biggs JC
Br J Haematol; 1986 May; 63(1):181-5. PubMed ID: 3518784
[TBL] [Abstract][Full Text] [Related]
13. Difference of cell lineage expression of haematopoietic progenitor cells in Philadelphia-positive acute lymphoblastic leukaemia and chronic myelogenous leukaemia.
Kitano K; Sato Y; Suda T; Miura Y
Br J Haematol; 1988 Sep; 70(1):21-6. PubMed ID: 3179225
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A).
Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inveradi D; Bernasconi P; Mancini M; Grignani F; Bernasconi C
Cancer Treat Rev; 1988 Jan; 15 Suppl A():21-6. PubMed ID: 3277708
[No Abstract] [Full Text] [Related]
15. [Two busulfan-resistant cases of CML (chronic myelogenous leukemia) with good response to alpha-interferon treatment].
Ogura H; Shirafuji N; Kumakawa T; Matsuda S; Horiuchi N; Kodo H; Fujii H; Asano S; Miwa S; Shinohara T
Rinsho Ketsueki; 1987 Sep; 28(9):1599-604. PubMed ID: 3481405
[No Abstract] [Full Text] [Related]
16. Interferon alfa-2b in the treatment of chronic myelogenous leukemia.
Niederle N; Kloke O; Osieka R; Wandl U; Opalka B; Schmidt CG
Semin Oncol; 1987 Jun; 14(2 Suppl 2):29-35. PubMed ID: 3473689
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with interferon alfa-2a in the chronic phase of Philadelphia-positive chronic myeloid leukemia].
Steegmann JL; Lavilla E; Somolinos N; Pérez-Sánchez M; Lamana M; Olmeda F; Cámara R; Arranz R; Ferro MT; Fernández-Rañada JM
Sangre (Barc); 1992 Oct; 37(5):375-81. PubMed ID: 1293778
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia.
Talpaz M; McCredie KB; Mavligit GM; Gutterman JU
Blood; 1983 Sep; 62(3):689-92. PubMed ID: 6192858
[TBL] [Abstract][Full Text] [Related]
19. The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
Bergsagel DE; Messner H
Br J Cancer; 1990 Jun; 61(6):895-8. PubMed ID: 2372493
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies of alpha-interferons in chronic myelogenous leukemia.
Talpaz M
Cancer Treat Rev; 1988 Jan; 15 Suppl A():49-53. PubMed ID: 3277710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
